Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy

被引:18
|
作者
Vijande, Javier [1 ,2 ]
Ballester, Facundo [1 ]
Ouhib, Zoubir [3 ]
Granero, Domingo [4 ]
Carmen Pujades-Claumarchirant, M. [5 ]
Perez-Calatayud, Jose [5 ]
机构
[1] Univ Valencia, Dept Atom Mol & Nucl Phys, E-46100 Burjassot, Spain
[2] Univ Valencia, CSIC, IFIC, Paterna, Valencia, Spain
[3] Boca Raton Reg Hosp, Lynn Canc Inst, Boca Raton, FL USA
[4] Hosp Gen Univ, ERESA, Dept Radiat Phys, Valencia, Spain
[5] La Fe Univ Hosp, Dept Radiat Oncol, Valencia, Spain
关键词
Ir-192; Brachytherapy; Dosimetry; Penelope2008; Freiburg flap; PARAMETERS; IR-192; APPLICATORS;
D O I
10.1016/j.brachy.2011.11.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: The purpose of this work was to evaluate whether the delivered dose to the skin surface and at the prescription depth when using a Freiburg flap applicator is in agreement with the one predicted by the treatment planning system (TPS) using the TG-43 dose-calculation formalism. METHODS AND MATERIALS: Monte Carlo (MC) simulations and radiochromic film measurements have been performed to obtain dose distributions with the source located at the center of one of the spheres and between two spheres. Primary and scatter dose contributions were evaluated to understand the role played by the scatter component. A standard treatment plan was generated using MC- and TG-43-based TPS applying the superposition principle. RESULTS: The MC model has been validated by performing additional simulations in the same conditions but transforming air and Freiburg flap materials into water to match TG-43 parameters. Both dose distributions differ less than 1%. Scatter defect compared with TG-43 data is up to 15% when the source is located at the center of the sphere and up to 25% when the source is between two spheres. Maximum deviations between TPS- and MC-based distributions are of 5%. CONCLUSIONS: The deviations in the TG-43-based dose distributions for a standard treatment plan with respect to the MC dose distribution calculated taking into account the composition and shape of the applicator and the surrounding air are lower than 5%. Therefore, this study supports the validity of the TPS used in clinical practice. (C) 2012 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:528 / 535
页数:8
相关论文
共 50 条
  • [1] DOSIMETRY COMPARISON BETWEEN TG-43 AND MONTE CARLO CALCULATIONS USING THE FREIBURG FLAP FOR SKIN HDR BRACHYTHERAPY
    Vijande, J.
    Ballester, F.
    Domingo, G.
    Ouhib, Z.
    Pujades, M. D. C.
    Perez-Calatayud, J.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S274 - S274
  • [2] Limitations of the TG-43 formalism for skin high-dose-rate brachytherapy dose calculations
    Granero, Domingo
    Perez-Calatayud, Jose
    Vijande, Javier
    Ballester, Facundo
    Rivard, Mark J.
    MEDICAL PHYSICS, 2014, 41 (02)
  • [3] Dose comparison between TG-43-based calculatiOns and radiochromic film measurements of the Freiburg flap applicator used for high-dose-rate brachytherapy treatments of skin lesions
    Aldelaijan, Saad
    Bekerat, Hamed
    Buzurovic, Ivan
    Devlin, Phillip
    DeBlois, Francois
    Seuntjens, Jan
    Devic, Slobodan
    BRACHYTHERAPY, 2017, 16 (05) : 1065 - 1072
  • [4] Limitations and Clinical Implications of the TG-43 Formalism for High-Dose-Rate Skin Brachytherapy
    Granero, D.
    Perez-Calatayud, J.
    Vijande, J.
    Ballester, F.
    Candela-Juan, C.
    Rivard, M.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [5] Monte Carlo study of TG-43 dosimetry parameters of GammaMed Plus high dose rate 192Ir brachytherapy source using TOPAS
    Wu, Jianan
    Xie, Yaoqin
    Ding, Zhen
    Li, Feipeng
    Wang, Luhua
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2021, 22 (06): : 146 - 153
  • [6] The validity of Acuros BV and TG-43 for high-dose-rate brachytherapy superficial mold treatments
    Boman, Eeva L.
    Satherley, Thomas W. S.
    Schleich, Nanette
    Paterson, Dean B.
    Greig, Lynne
    Louwe, Rob J. W.
    BRACHYTHERAPY, 2017, 16 (06) : 1280 - 1288
  • [7] Monte Carlo calculation of the relative TG-43 dosimetry parameters for the INTRABEAM electronic brachytherapy source
    Alvarez, David Santiago Ayala
    Watson, Peter G. F.
    Popovic, Marija
    Heng, Veng Jean
    Evans, Michael D. C.
    Seuntjens, Jan
    PHYSICS IN MEDICINE AND BIOLOGY, 2020, 65 (24):
  • [8] Dosimetric and radiobiological comparison of TG-43 and Monte Carlo calculations in 192Ir breast brachytherapy applications
    Peppa, V.
    Pappas, E. P.
    Karaiskos, P.
    Major, T.
    Polgar, C.
    Papagiannis, P.
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2016, 32 (10): : 1245 - 1251
  • [9] Monte Carlo dose calculations for high-dose-rate brachytherapy using GPU-accelerated processing
    Tian, Z.
    Zhang, M.
    Hrycushko, B.
    Albuquerque, K.
    Jiang, S. B.
    Jia, X.
    BRACHYTHERAPY, 2016, 15 (03) : 387 - 398
  • [10] Benchmarking BrachyDose: Voxel based EGSnrc Monte Carlo calculations of TG-43 dosimetry parameters
    Taylor, R. E. P.
    Yegin, G.
    Rogers, D. W. O.
    MEDICAL PHYSICS, 2007, 34 (02) : 445 - 457